Table 2. Patient demographics and tumor characteristics.
CHARACTERISTIC | INTRAHEPATIC (N = 55) | EXTRAHEPATIC (N = 20) |
Male | 16 (29%) | 13 (65%) |
Female | 39 (71%) | 7 (35%) |
Asian | 2 (4%) | 1 (5%) |
Hispanic | 8 (15%) | 0 (0%) |
Black | 3 (5%) | 0 (0%) |
White | 42 (76%) | 19 (95%) |
Poorly differentiated | 28 (47%) | 7 (35%) |
Moderate differentiated | 26 (48%) | 11 (55%) |
Well differentiated | 1 (2%) | 0 (0%) |
Grade N/A | 0 (0%) | 2 (10%) |
AJCC II | 4 (7%) | 6 (30%) |
AJCC III | 17 (31%) | 5 (25%) |
AJCC IV | 34 (62%) | 9 (45%) |
Surgery without adjuvant therapy | 7 (13%) | 7 (35%) |
Radiation therapy | 10 (18%) | 1 (5%) |
Surgery & adjuvant chemoradiation | 6 (11%) | 7 (35%) |
Systemic Therapy | 32 (58%) | 5 (25%) |